9 Result(s)

Article

Erratum to: Flt3 receptor inhibition reduces constitutive NFκB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

Jennifer Grosjean-Raillard, Lionel Adès, Simone Boehrer, Maximilien Tailler… in Apoptosis (2015)

Article

Validation of a post-hypomethylating agent failure prognostic model in myelodysplastic syndromes patients treated in a randomized controlled phase III trial of rigosertib vs. best supportive care

Aziz Nazha, Mikkael A. Sekeres, Rami Komrokji, David P. Steensma… in Blood Cancer Journal (2017)

Article

The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q)

Mikkael A. Sekeres, Arlene S. Swern, Aristoteles Giagounidis… in Blood Cancer Journal (2018)

Article

Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis

Peripheral blood monocytes include three subsets defined by CD14 and CD16 surface markers. An increase in the CD14⁺⁺CD16⁻ classical monocyte fraction ≥ 94% of the total monocytes was proposed to rapidly and effic...

Sihem Tarfi, Véronique Harrivel, Florent Dumezy, Julien Guy… in Blood Cancer Journal (2018)

Article

Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

A Correction to this paper has been published: https://doi.org/10.1038/s41591-021-01253-5.

Elsa Bernard, Yasuhito Nannya, Robert P. Hasserjian, Sean M. Devlin… in Nature Medicine (2021)

Article

Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Elsa Bernard, Yasuhito Nannya, Robert P. Hasserjian, Sean M. Devlin… in Nature Medicine (2021)

Article

Machine learning-based improvement of MDS-CBC score brings platelets into the limelight to optimize smear review in the hematology laboratory

Myelodysplastic syndromes (MDS) are clonal hematopoietic diseases of the elderly characterized by chronic cytopenias, ineffective and dysplastic haematopoiesis, recurrent genetic abnormalities and increased ri...

Jaja Zhu, Pierre Lemaire, Stéphanie Mathis, Emily Ronez, Sylvain Clauser… in BMC Cancer (2022)

Article

The ABNL-MARRO 001 study: a phase 1–2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes

Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) comprise several rare hematologic malignancies with shared concomitant dysplastic and proliferative clinicopathologic features of bone marrow failure and ...

Tamara K. Moyo, Jason H. Mendler, Raphael Itzykson, Ashwin Kishtagari… in BMC Cancer (2022)

Article

Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M

David Fandrei, Tony Huynh, Marie Sébert, Lorea Aguinaga… in Blood Cancer Journal (2023)